Omers Administration Corp Innoviva, Inc. Transaction History

Omers Administration Corp

  • $10.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$14.56 - $16.78 $347,984 - $401,042
-23,900 Reduced 63.73%
13,600 $207,000
Q4 2023

Feb 13, 2024
SELL
$12.32 - $16.27 $60,368 - $79,723
-4,900 Reduced 11.56%
37,500 $601,000
Q3 2023

Nov 13, 2023
BUY
$12.37 - $13.89 $524,488 - $588,936
42,400 New
42,400 $550,000

Others Institutions Holding INVA

# of Institutions
227
Shares Held
78.9M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.23B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Omers Administration Corp Portfolio

Follow Omers Administration Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

News

Stay updated on Omers Administration Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email